Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic

IntroductionThis study aimed to investigate the effect of smoking cessation on plasma clozapine (CLO) concentrations in long-term hospitalized Chinese male patients with schizophrenia treated with CLO during the COVID-19 pandemic.MethodsTherapeutic drug monitoring (TDM) data for CLO were collected a...

Full description

Bibliographic Details
Main Authors:	Botao Ma, Hongzhen Fan, Siyuan Qi, Fude Yang, Huimei An
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Psychiatry
Subjects:	clozapine schizophrenia smoking cessation therapeutic drug monitoring plasma concentrations
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1256264/full

Similar Items

Case report: Time response of plasma clozapine concentrations on cessation of heavy smoking
by: Lingyan Qi, et al.
Published: (2024-06-01)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
by: I. Kammoun, et al.
Published: (2022-06-01)

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
by: Mayerova M, et al.
Published: (2018-06-01)

Efficacy of clozapine in patients with chronic schizophrenia
by: Varuni de Silva, et al.
Published: (2010-12-01)

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
by: Arnim Johannes Gaebler, et al.
Published: (2023-04-01)

Efficacy of clozapine in patients with chronic schizophrenia
by: Varuni de Silva, et al.
Published: (2010-12-01)

Influence of cigarette smoking habit on clozapine-to-norclozapine ratio in male patients
by: Roberto Lozano, et al.
Published: (2023-01-01)

Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
by: Saeed Ahmed, et al.
Published: (2018-09-01)

Strategies in clozapine-resistant schizophrenia: A literature review
by: Ganesh Kundadak Kudva, et al.
Published: (2016-01-01)

CLOZAPINE ON PARANOID SCHIZOPHRENIA WITH OBESITY: A CASE REPORT
by: Dewa Nyoman Krisna Arijaya
Published: (2015-05-01)

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
by: Xuechan Lyu, et al.
Published: (2018-03-01)

Effective and underprescribed: what about clozapine?
by: Helge H.O. Müller
Published: (2017-10-01)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
by: Paria Hebrani, et al.
Published: (2015-01-01)

Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
by: Amina Aissa, et al.
Published: (2022-01-01)

Electroconvulsive therapy in a patient with resistant paranoid schizophrenia treated with clozapine
by: S. Castelao-Almodóvar, et al.
Published: (2021-04-01)

The effect of clozapine on immune-related biomarkers in schizophrenia patients
by: Lu Shao, et al.
Published: (2024-11-01)

Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
by: Hana Hribkova, et al.
Published: (2022-02-01)

Editorial: Smoking and Schizophrenia
by: David Castle, et al.
Published: (2019-10-01)

Arrhythmia induced by clozapine in patients with schizophrenia： a Meta-analysis
by: Chen Yadi, et al.
Published: (2024-10-01)

Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
by: Mitesh Kumar, et al.
Published: (2017-01-01)

Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)

Pharmacogenetics in schizophrenia: a review of clozapine studies
by: Fabiana Barzotti Kohlrausch
Published: (2013-09-01)

Effect of Common Cold on Serum Clozapine Concentrations in Hospitalized Patients with Schizophrenia
by: Cao Y, et al.
Published: (2024-08-01)

Comparison effects of clozapine, ECT and combination ECTand clozapine on resistance treatment of schizophrenia(Double blind)
by: S.H. Hosseini, et al.
Published: (2006-01-01)

History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study
by: Yi Yin, et al.
Published: (2024-06-01)

Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study
by: Yuta Kawakita, et al.
Published: (2022-10-01)

Resistant schizophrenia in a patient with oculocutaneous albinism successfully treated with clozapine
by: A. Jelti, et al.
Published: (2022-06-01)

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
by: Marcin Siwek, et al.
Published: (2023-03-01)

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
by: De las Cuevas C, et al.
Published: (2024-11-01)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
by: H. Becerra Darriba
Published: (2021-04-01)

Interventions for smoking cessation
by: D. Ariyasinghe, et al.
Published: (2017-12-01)

The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
by: Anna Mach, et al.
Published: (2025-01-01)

Comparative effects of clozapine and risperidone monotherapy on levels of immunoglobulins in patients with schizophrenia – A 12 weeks' longitudinal study
by: Sumeesha Jaswal, et al.
Published: (2022-01-01)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
by: Shusuke Numata, et al.
Published: (2018-09-01)

Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series
by: Duque-Yemail JD, et al.
Published: (2022-07-01)

An observational study of the effects of smoking cessation earlier on the clinical characteristics and course of acute exacerbations of chronic obstructive pulmonary disease
by: Xiaolong Li, et al.
Published: (2022-10-01)

Clozapine induced severe weight loss in resistant schizophrenia managed with risperidone add-on therapy
by: M. Chandradasa, et al.
Published: (2020-12-01)

Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
by: Ming-Huan Zhu, et al.
Published: (2022-10-01)

Activation of Astroglial Connexin Is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine
by: Kouji Fukuyama, et al.
Published: (2020-02-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01)